What is the Return on Assets (ROA) of Cochlear this year?
The Return on Assets (ROA) of Cochlear is 0.12 undefined this year.
In 2024, Cochlear's return on assets (ROA) was 0.12, a -0.22% increase from the 0.12 ROA in the previous year.
Cochlear's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Comparing Cochlear's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Investors consider Cochlear's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Variations in Cochlear’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
The Return on Assets (ROA) of Cochlear is 0.12 undefined this year.
The ROA of Cochlear has increased by -0.22% compared to the previous year.
A high ROA is advantageous for investors of Cochlear, as it indicates that the company efficiently utilizes its assets and generates good profits.
A low ROA can be unfavorable for investors of Cochlear as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
An increase in ROA of Cochlear can be an indicator of improved efficiency in asset utilization and higher profitability.
A reduction in the ROA of Cochlear can be an indicator of lower asset efficiency and profitability.
Some factors that can influence the ROA of Cochlear include revenue, operating costs, asset structure, and industry average.
The ROA of Cochlear is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
To improve ROA, Cochlear can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
Over the past 12 months, Cochlear paid a dividend of 4.06 AUD . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Cochlear is expected to pay a dividend of 4.25 AUD.
The current dividend yield of Cochlear is 1.2 %.
Cochlear pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Cochlear paid dividends every year for the past 27 years.
For the upcoming 12 months, dividends amounting to 4.25 AUD are expected. This corresponds to a dividend yield of 1.26 %.
Cochlear is assigned to the 'Health' sector.
To receive the latest dividend of Cochlear from 4/15/2024 amounting to 2.6 AUD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.
The last dividend was paid out on 4/15/2024.
In the year 2023, Cochlear distributed 3.249 AUD as dividends.
The dividends of Cochlear are distributed in AUD.
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.